CYP24 inhibition preserves 1α,25-dihydroxyvitamin D(3) anti-proliferative signaling in lung cancer cells.
about
The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms.Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk.VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cells.Inhibition of protein kinase CK2 reduces Cyp24a1 expression and enhances 1,25-dihydroxyvitamin D(3) antitumor activity in human prostate cancer cells.Serum 1,25-dihydroxyvitamin D: an outcome prognosticator in human sepsisVitamin D Repletion Reduces the Progression of Premalignant Squamous Lesions in the NTCU Lung Squamous Cell Carcinoma Mouse Model.Simultaneous Quantification of 25-Hydroxyvitamin D3 and 24,25-Dihydroxyvitamin D3 in Rats Shows Strong Correlations between Serum and Brain Tissue Levels.Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo.Vitamin D deficiency and the lung: disease initiator or disease modifier?1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)2D3 in NSCLC Treatment.Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1.Differential response to 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) in non-small cell lung cancer cells with distinct oncogene mutations.24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics.Increased CYP24A1 expression is associated with BRAF(V600E) mutation and advanced stages in papillary thyroid carcinoma.Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.Vitamin D-neutralizing CYP24A1 expression, oncogenic mutation states and histological findings of human papillary thyroid cancer.Vitamin D in prostate cancer.
P2860
Q30235880-49E694B6-7BBB-4BA8-9907-1381F0BD81C5Q30380765-B15262B7-DDE1-4D9B-A549-1C95EC40630DQ34053767-3D3E63CA-03AD-47CF-8BD9-36AC24AAA237Q34566030-398D814E-30D9-42C6-AF83-EE15D1074754Q34760458-859FCD4F-BC30-41A3-B997-C6B1C92C284EQ36332442-C8A686D1-347D-4746-85CD-75001169075AQ36374495-622E6E9A-C1B7-4F09-8D56-C954D396757CQ36729586-B28093BF-6542-4A6C-81FD-E2195C00A8ADQ37177373-E5C4A7C9-291C-4DFD-BA67-B285DDC5C6F1Q37420597-9FF4565B-EB5F-4038-B332-FCF033A0A62CQ37718405-48DB77C9-40C7-4C51-971B-B36E7A620A03Q38048501-A08D18D3-8E7A-4525-AD3D-414EF40C347DQ38051505-4E9068CA-6037-4EC7-9953-ABF7352AD8A1Q39037968-E29C24FC-A364-4C72-A418-3F089A12A86AQ47107773-273694CA-6503-4D99-8426-A15C36AE8EB0Q54324154-B4916DB6-848B-40CA-B0E9-308BE7D4589EQ55024961-F95043C5-ADD2-4CD3-91EB-7A7192A1CEC1
P2860
CYP24 inhibition preserves 1α,25-dihydroxyvitamin D(3) anti-proliferative signaling in lung cancer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
CYP24 inhibition preserves 1α, ...... ignaling in lung cancer cells.
@en
CYP24 inhibition preserves 1α, ...... ignaling in lung cancer cells.
@nl
type
label
CYP24 inhibition preserves 1α, ...... ignaling in lung cancer cells.
@en
CYP24 inhibition preserves 1α, ...... ignaling in lung cancer cells.
@nl
prefLabel
CYP24 inhibition preserves 1α, ...... ignaling in lung cancer cells.
@en
CYP24 inhibition preserves 1α, ...... ignaling in lung cancer cells.
@nl
P2093
P2860
P1476
CYP24 inhibition preserves 1α, ...... signaling in lung cancer cells
@en
P2093
Beatriz Kanterewicz
Martin Petkovich
Pamela A Hershberger
Qiuhong Zhang
Robert Parise
Shama Buch
P2860
P304
P356
10.1016/J.MCE.2012.02.006
P577
2012-02-22T00:00:00Z